ATLASVir Biotechnology (VIR) earnings date: Nov 4, 2026
Vir Biotechnology (VIR) reports earnings for the quarter ended Sep 30, 2026 on Wed, Nov 4, 2026, after the close. Analysts expect EPS of -$0.75.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on VIR
| Last price | $11.18 (-1.1%) |
|---|---|
| Normal 1-day range (±1σ) | ±3.3% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Vir Biotechnology stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Vir Biotechnology reports on Nov 4, 2026. One email the day before, with ATLAS’s read on Vir Biotechnology. You can switch it off at any time.
Alert me before VIR reportsFree to start. Creating an account takes under a minute.
Notify me when Vir Biotechnology reports
Track VIR free Add Vir Biotechnology to a free ATLAS watchlist and see its next report date in one place.
VIR earnings at a glance
| Next report (confirmed) | Wed, Nov 4, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.75 |
| Last report | Aug 5, 2026 · Miss |
| Beat rate (last 5 reports) | 2 of 5 (40%) |
| Average EPS surprise | -71.1% |
| Average move around a report | ±9.3% (last 5) |
| Sector | Healthcare · Biotechnology |
Vir Biotechnology earnings history: last 5 reports
Vir Biotechnology last reported on Aug 5, 2026: EPS of $0.47 against an estimate of $0.90 (-47.8% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 5, 2026 | $0.90 | $0.47 | -47.8% | Miss | -4.4% |
| May 28, 2026 | $1.23 | $1.28 | +4.1% | Beat | +4.8% |
| May 6, 2026 | $0.48 | -$0.85 | -277.1% | Miss | -7.4% |
| Feb 23, 2026 | -$0.45 | -$0.31 | +31.1% | Beat | +25.5% |
| Nov 25, 2025 | $3.41 | $1.16 | -66.0% | Miss | +4.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for VIR
See the fair value, the probability range and the earnings history of Vir Biotechnology on its ATLAS page.
Vir Biotechnology (VIR) stock analysisPlans from €3.99 a month.
Vir Biotechnology earnings: frequently asked questions
When does Vir Biotechnology (VIR) report earnings?
Vir Biotechnology is scheduled to report on Wednesday, November 4, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for VIR?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.75 per share (USD). Estimates can change before the report.
How often does VIR beat earnings estimates?
Of its last 5 reports with a recorded result, Vir Biotechnology beat the EPS estimate 2 times; the average surprise was -71.1%. Past results do not predict the next one.
How much does VIR move around earnings?
Over its last 5 reports the stock moved an average of 9.3% (absolute, from the close before the report day to the close after it), and finished higher 3 of 5 times.
Did Vir Biotechnology beat earnings estimates last quarter?
Vir Biotechnology last reported on Aug 5, 2026: EPS of $0.47 against an estimate of $0.90 (-47.8% surprise), a miss.
How much does VIR usually move in a day?
On a normal trading day the ATLAS model puts VIR’s one-day range at about ±3.3%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Wed, Nov 4, 2026
Educational information, not investment advice. Disclaimer